Genomic Sequencing Explains How Scientists Detect New COVID-19 Variants
Researchers use rapid DNA sequencing to track mutations in the SARS-CoV-2 virus, revealing how variants like Omicron change their transmissibility and ability to evade immune defenses.
Scientists use a process called genomic sequencing to identify new COVID-19 variants by reading the exact order of chemical building blocks that make up the virus's genetic material. When the SARS-CoV-2 virus replicates, random copying errors create mutations that swap, delete, or insert these genetic blocks. These genetic changes alter the virus's proteins, which ultimately affects its physical characteristics, including how easily it spreads and its ability to evade the human immune system.
The underlying technology driving this surveillance relies on determining the precise sequence of nucleotides—adenine, thymine, cytosine, and guanine—within an organism's genome. While early methods like Sanger sequencing required cutting DNA into short fragments and using radioactive or fluorescent tags to identify each block, the technology has advanced dramatically. What once took two decades to accomplish for the first human genome now takes only a matter of hours, allowing for real-time tracking of a rapidly evolving global pandemic.
Microbiologists and biochemists apply these same advanced sequencing tools to monitor the coronavirus as it circulates through the population. By continuously comparing the genetic blueprints of emerging virus samples against known variants, researchers quickly spot dangerous new mutations. This constant genetic surveillance provides public health officials with the critical early warnings needed to respond to highly transmissible or immune-evading variants like Omicron.